World's Best Scientists 2026 revealed!
Hanneke Schuitemaker

Hanneke Schuitemaker

Award Badge
Immunology
Austria
2026
Award Badge
Immunology
Belgium
2025

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 100 724 668 5 5 426 38589
Medicine 100 8252 7760 42 40 426 38589

Hanneke Schuitemaker publications per year

The chart shows the history of publications by Hanneke Schuitemaker between 1990 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Hanneke Schuitemaker published across 36 years, from 1990 to 2025, averaging 12 papers a year. Output peaked at 31 publications in 2021. 17 of the 431 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1990 to 2025. Vertical axis: number of publications, 0 to 31. Peak 31 publications in 2021. 1990: 1 publication 1991: 1 publication 1992: 9 publications 1993: 6 publications 1994: 13 publications 1995: 12 publications 1996: 10 publications 1997: 11 publications 1998: 23 publications 1999: 14 publications 2000: 13 publications 2001: 9 publications 2002: 11 publications 2003: 11 publications 2004: 7 publications 2005: 14 publications 2006: 3 publications 2007: 15 publications 2008: 15 publications 2009: 20 publications 2010: 15 publications 2011: 24 publications 2012: 21 publications 2013: 13 publications 2014: 5 publications 2015: 14 publications 2016: 8 publications 2017: 6 publications 2018: 13 publications 2019: 5 publications 2020: 13 publications 2021: 31 publications 2022: 23 publications 2023: 5 publications 2024: 14 publications 2025: 3 publications
1990 2025

431 publications in total across all disciplines

View publications per year as a table
Hanneke Schuitemaker: publications per year, 1990 to 2025
Year Publications
1990 1
1991 1
1992 9
1993 6
1994 13
1995 12
1996 10
1997 11
1998 23
1999 14
2000 13
2001 9
2002 11
2003 11
2004 7
2005 14
2006 3
2007 15
2008 15
2009 20
2010 15
2011 24
2012 21
2013 13
2014 5
2015 14
2016 8
2017 6
2018 13
2019 5
2020 13
2021 31
2022 23
2023 5
2024 14
2025 3
Total 431
Download as CSV

Hanneke Schuitemaker publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hanneke Schuitemaker sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 422–431 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 426 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63 426
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Hanneke Schuitemaker D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hanneke Schuitemaker sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 100–101 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 100 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49 100
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in Austria Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award

Overview

Hanneke Schuitemaker is affiliated with Janssen (Belgium) and has conducted extensive research primarily in the field of medicine, with a strong focus on infectious diseases. Their work encompasses various domains such as epidemiology, virology, genetics, and molecular biology.

The scientist's main research topics include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Virus-based gene therapy research
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing

Schuitemaker has published numerous papers, often collaborating with several frequent co-authors such as Dan H. Barouch, Roland Zahn, Frank Wegmann, Mathieu Le Gars, and Macaya Douoguih. Their research findings have appeared in a range of scientific journals.

Notable recent papers include:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine, 2021, New England Journal of Medicine
  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques, 2020, Nature
  • Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses, 2020, npj Vaccines
  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans, 2021, Nature

Frequent publication venues for Schuitemaker's work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines
  • Nature Communications
  • The Journal of Infectious Diseases
  • New England Journal of Medicine

Schuitemaker's contributions span over a hundred publications related to infectious diseases, with a particular emphasis on SARS-CoV-2 and COVID-19 research. Their involvement in vaccine development is reflected in studies of the Ad26.COV2.S vaccine, which appears prominently among their publications. This research highlights aspects such as safety, efficacy, immunogenicity, and protective effects of vaccine candidates against COVID-19.

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

    H Schuitemaker;M Koot;N A Kootstra;M W Dercksen

  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.

    Jerald Sadoff;Mathieu Le Gars;Georgi Shukarev;Dirk Heerwegh

  • A new classification for HIV-1

    E. A. Berger;R. W. Doms;E.-M. Fenyö;B. T. M. Korber

  • Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

    R A Fouchier;M Groenink;N A Kootstra;M Tersmette

  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

    Noe B. Mercado;Roland Zahn;Frank Wegmann;Carolin Loos;Carolin Loos

  • Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

    M R Klein;C A van Baalen;A M Holwerda;S R Kerkhof Garde

  • Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

    A B van't Wout;N A Kootstra;G A Mulder-Kampinga;N Albrecht-van Lent

  • Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.

    Hugo Mouquet;Louise Scharf;Zelda Euler;Yan Liu

  • T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

    Mette D. Hazenberg;Dörte Hamann;Hanneke Schuitemaker;Frank Miedema

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.

    H. Schuitemaker;N. A. Kootstra;R. E. Y. De Goede;F. De Wolf

  • In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

    Hetty Blaak;Angélique B. van't Wout;Margreet Brouwer;Berend Hooibrink

  • Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

    J. P.A. Ioannidis;P. S. Rosenberg;J. J. Goedert;L. J. Ashton

  • Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

    A.M. de Roda Husman;M. Koot;M.T.E. Cornelissen;I.P.M. Keet

  • A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

    Anders Krarup;Daphné Truan;Polina Furmanova-Hollenstein;Lies Bogaert

  • Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized Clinical Trial

    Iain D. Milligan;Malick M. Gibani;Richard Sewell;Elizabeth A. Clutterbuck

  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    Unknown

  • Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.

    Lisa H. Tostanoski;Frank Wegmann;Amanda J. Martinot;Amanda J. Martinot;Carolin Loos;Carolin Loos

  • Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Kathryn E. Stephenson;Erica N. Borducchi;Kaitlin Smith

  • Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes

    Steven W. de Taeye;Gabriel Ozorowski;Alba Torrents de la Peña;Miklos Guttman

  • Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

    Amy W. Chung;Amy W. Chung;Manu P. Kumar;Kelly B. Arnold;Wen Han Yu;Wen Han Yu

Frequent Co-Authors

Neeltje A. Kootstra
Neeltje A. Kootstra University of Amsterdam
Frank Miedema
Frank Miedema Utrecht University
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Jan M. Prins
Jan M. Prins University of Amsterdam
Suzanne Jurriaans
Suzanne Jurriaans University of Amsterdam
Ronald P. van Rij
Ronald P. van Rij Radboud University
Jean-François Zagury
Jean-François Zagury heSam Université

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare and research careers. For those interested in the clinical aspect, exploring the best online pmhnp programs can be a great way to advance into psychiatric nursing with strong clinical training. These programs often offer excellent placement rates, ensuring practical experience alongside theoretical knowledge.

Cost is a significant factor for many students. To find budget-friendly options, consider the cheapest online pmhnp certificate programs that balance affordability with quality education. This can make specialized nursing degrees more accessible without compromising on standards.

Understanding career prospects is crucial. For nurse practitioners with doctoral degrees, knowing how much do dnp nurses make can help set realistic financial goals and plan for future growth. Salaries vary by state and specialization, making this information valuable for career planning.

Finally, those looking to expand their scope might explore certification options such as acute care np certification. Transitioning from family nurse practitioner roles to acute care can enhance expertise and open new clinical opportunities in critical care settings.

Best Scientists Citing Hanneke Schuitemaker

Trending Scientists

Recently Published Articles